Robert-Jan Smits, Director-General for Research and Innovation, presents the vaccine prize at the Innovation Convention 2014
10/03/2014: German biopharmaceutical company CureVac GmbH has won the Vaccine Prize!
Read the full press release and watch the prize ceremony.
20/12/2013: 12 entries were assessed by the Vaccine Prize jury during October/November 2013. The jury has now made its recommendations to the European Commission, and all competitors have now been informed of the jury’s opinion on their entry. The name of the winner will be announced at the European Commission’s Innovation Convention 10th and 11th March 2014, and on this website shortly after.
23/05/2013: clarification on the application procedure: the 49 registered competitors have until 3 September 2013 to present their applications in the way which they consider best satisfies the competition criteria, though some rules do apply: as stated in the competition rules ( 416KB), the application must consist of a summary of no more than 20 pages and may include an annex of no more than 20 pages (in both cases Times New Roman, minimum font size 10). The jury will be instructed to disregard any additional information presented in the application.
30/04/2013: 49 eligible competitors have registered their participation in the Vaccine Prize by the 30 April 2013 deadline for registration.
About the prize:
Many people in tropical and developing countries cannot benefit from life-saving vaccines because these vaccines are damaged during transport and storage. Many vaccines need to be kept at a cool and stable temperature to remain effective and this is difficult to ensure in these regions.
The European Commission is offering a EUR 2 million prize for innovations which can solve this global health problem to legal entities in the EU or in a country associated with the 7th Research Framework Programme.
No particular approach is prescribed. Solutions may include alternative ways of formulating, preserving or transporting vaccines. Whichever solution responds best to the competition criteria will win.
The European Commission will be advised on the winner by the jury ( 288KB), composed of leading experts with a variety of professional experience in vaccine development, regulation, use, formulation, preservation.
Competition rules and FAQ
Please download the full competition rules ( 416KB) and frequently asked questions ( 187KB) to learn more about the requirements, evaluation criteria and selection process.
If you can't find the information you are looking for send us your question by E-mail and we will get back to you.